Vanguard Group Inc Kodiak Sciences Inc. Call Options Transaction History
Vanguard Group Inc
- $5.37 Trillion
- Q1 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding KOD
# of Institutions
110Shares Held
41.6MCall Options Held
10.9KPut Options Held
700-
Baker Bros. Advisors LP New York, NY17.3MShares$142 Million0.58% of portfolio
-
Black Rock Inc. New York, NY3.85MShares$31.6 Million0.0% of portfolio
-
Acadian Asset Management LLC Boston, MA1.97MShares$16.2 Million0.02% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA1.33MShares$10.9 Million0.01% of portfolio
-
Iconiq Capital, LLC San Francisco, CA1.27MShares$10.4 Million0.09% of portfolio
About Kodiak Sciences Inc.
- Ticker KOD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,040,200
- Market Cap $427M
- Description
- Kodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases. Its lead product candidate is KSI-301, an anti-vascular endothelial growth factor antibody biopolymer that is in Phase IIb/III clinical study to treat wet age-related macular degeneration (AMD), as we...